Drugs / EO-3021
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05980416 | Aug 2023 → May 2025 | gastric neoplasm | Elevation Oncology | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EO-3021 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05980416 ↗ |
| Modality | Other / unclassified | “Anti-Claudin 18.2 antibody drug conjugate” NCT05980416 ↗ |